VALSTAR® (valrubicin) Official Patient Site
VALSTAR ® (valrubicin) is a liquid medicine put directly into the bladder with flexible tubing called a catheter. VALSTAR ® is used for patients whose CIS bladder cancer did not respond to treatment with a drug called BCG or Bacillus Calmette-Guerin and who cannot have surgery right away to take out the bladder. You should not receive VALSTAR ...
VALSTAR (valrubicin) Sterile Solution For Intravesical Instillation
VALSTAR ® (valrubicin) is a liquid medicine put directly into the bladder with flexible …
Images Of Valstar Valrubicin
VALSTAR ® (valrubicin) is a liquid medicine put directly into the bladder with flexible …
Valrubicin - National Cancer Institute
VALSTAR ® (valrubicin) Sterile Solution for Intravesical Instillation is intended for intra-vesical administration in the urinary bladder. It is supplied as a nonaqueous solution that should be diluted before intravesical administration. Each vial of VALSTAR contains valrubicin at a concentration of 40 mg/mL in 50% polyoxyl castor oil/50% dehydrated alcohol, USP without …
Valstar (Valrubicin): Uses, Dosage, Side Effects, …
31/10/2017 · Valstar. FDA Approved. Yes. FDA label information for this drug is available at DailyMed. Use in Cancer. Valrubicin is approved to treat: Bladder cancer. It is given directly into the bladder as a treatment for carcinoma in situ that does not respond to treatment with bacillus Calmette-Guérin (BCG). It is used in patients who cannot have surgery right away. More …
Valstar (valrubicin) For Bladder Cancer: Side Effects, …
13/01/2022 · VALSTAR® (valrubicin) Sterile Solution for Intravesical Instillation is intended for intra-vesical administration in the urinary bladder. It is supplied as a nonaqueous solution that should be diluted before intravesical administration. Each vial of VALSTAR contains valrubicin at a concentration of 40 mg/mL in 50% polyoxyl castor oil/50% dehydrated alcohol, USP without …
Valrubicin - Wikipedia
02/04/2021 · Valstar (valrubicin) is a cancer medication used to treat bladder cancer. Common side effects of Valstar include bladder irritation (symptoms such as pain, spasm, frequent urge to urinate, and blood in the urine), urinary incontinence, urinary tract infection, and nausea.
Preparation And Administration Guide - VALSTAR® (valrubicin) …
Valrubicin (N-trifluoroacetyladriamycin-14-valerate, trade name Valstar) is a chemotherapy drug used to treat bladder cancer. Valrubicin is a semisynthetic analog of the anthracycline doxorubicin, and is administered by infusion directly into the bladder. It was originally launched as Valstar in the U.S. in 1999 for intravesical therapy of Bacille Calmette-Guérin (BCG) …
Valstar (Valrubicin) For Bladder Cancer
VALSTAR® (valrubicin) is indicated for intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality. Important Safety Information • VALSTAR is contraindicated in patients with known hypersensitivity to anthracyclines or polyoxyl castor oil. VALSTAR …
NDC 67979-001 Valstar Valrubicin
Valstar (Valrubicin) is a chemotherapeutic drug that inhibits the cell cycle in the G phase.It is used in the treatment of BCG-refractory bladder carcinoma.
Drug Approval Package: Valstar (Valrubicin) NDA# 20-892
VALSTAR contains valrubicin (N-trifluoroacetyladriamycin-14-valerate), which is a semisynthetic analog of the anthracycline doxorubicin as a cytotoxic agent. The chemical name of valrubicin is (2 S- cis)-2-[1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-α-L- lyxo-hexopyranosyl]oxyl]-2-naphthacenyl]-2-oxoethylpentanoate. …